Browse studies

Find your next paid study

5 recruiting studies matching your filters

A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream in Adult Participants With Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period

The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of a…

Lichen Sclerosus

Estimated

~$10 – $8,750

LEO PharmaNCT07335588

Phase 2

Nemolizumab for the Treatment of Lichen Sclerosus

Patients ≥ 18 years of age with Lichen sclerosis (LS)

Lichen Sclerosus of Vulva

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07704775

Observational

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will b…

Atrophic VaginitisVaginal AtrophyGenitourinary Syndrome of Menopause+3 more

Estimated

~$10 – $8,750

Stratpharma AGNCT05953090

Phase 2

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

We are looking to see if patients using both topical testosterone and estrogen will have a greater improvement in pain with vaginal penetration compared to tho…

VulvodyniaDyspareuniaLichen Sclerosus of Vulva

Estimated

~$10 – $8,750

TriHealth Inc.NCT07260825

Phase 1

A Double Blind Placebo-controlled Trial of StrataMGT for the Management of Vulvar Lichen Sclerosus Symptoms.

This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.

Vulvar Lichen Sclerosus

Estimated

~$10 – $7,500

Andrew T. Goldstein, MDNCT06662942